Metall Zug

Miele and Metall Zug Group formed a joint venture, SteelcoBelimed, combining Miele's Steelco Group and Metall Zug's Belimed Infection Control and Life Science businesses. Miele holds 67% and Metall Zug 33%. The joint venture is operational immediately.

Metall Zug and Miele completed the establishment of a joint venture named SteelcoBelimed AG, combining Belimed Infection Control, Belimed Life Science and Steelco. Metall Zug holds 33% and Miele 67% of the new company, which has accumulated net sales of CHF 487 million in 2023 and employs around 2,100 people.

Metall Zug and Miele have completed a joint venture, bringing together Steelco and Belimed in the field of Infection Control and Life Science, forming a new brand called SteelcoBelimed. The joint venture was completed on June 10, 2024.

Metall Zug and Miele have signed an agreement to create a joint venture combining Belimed and Steelco. Metall Zug will hold 33% and Miele 67% of the new company based in Zug, Switzerland.

Metall Zug Group has signed an agreement to acquire 70% of Haag-Streit Holding AG, a Swiss medtech company specializing in ophthalmology and surgical microscopy. The remaining 30% will stay with family shareholders. The transaction is expected to close in Q1 2018.